Annual ROE
-84.92%
-34.62%-68.83%
December 31, 2024
Summary
- As of March 15, 2025, NMRA annual return on equity is -84.92%, with the most recent change of -34.62% (-68.83%) on December 31, 2024.
- During the last 3 years, NMRA annual ROE has fallen by -157.89% (-216.38%).
- NMRA annual ROE is now -180.74% below its all-time high of 105.18%, reached on December 1, 2020.
Performance
NMRA ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-68.98%
+4.65%+6.32%
December 31, 2024
Summary
- As of March 15, 2025, NMRA quarterly return on equity is -68.98%, with the most recent change of +4.65% (+6.32%) on December 31, 2024.
- Over the past year, NMRA quarterly ROE has increased by +4.65% (+6.32%).
- NMRA quarterly ROE is now -159.12% below its all-time high of 116.68%, reached on September 1, 2021.
Performance
NMRA Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
NMRA ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -68.8% | +6.3% |
| 3 y3 years | -216.4% | -185.9% |
| 5 y5 years | - | -185.9% |
NMRA ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -216.4% | at low | -166.3% | +54.4% |
| 5 y | 5-year | -180.7% | at low | -159.1% | +54.4% |
| alltime | all time | -180.7% | at low | -159.1% | +54.4% |
Neumora Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | -84.92%(+68.8%) | -68.98%(-6.3%) |
| Sep 2024 | - | -73.63%(+20.0%) |
| Jun 2024 | - | -61.35%(-46.1%) |
| Mar 2024 | - | -113.81%(-24.7%) |
| Dec 2023 | -50.30%(-271.7%) | -151.16%(-245.2%) |
| Sep 2023 | - | 104.09%(+279.6%) |
| Jun 2023 | - | 27.42%(-6.6%) |
| Mar 2023 | - | 29.35%(-9.7%) |
| Dec 2022 | 29.29% | 32.52%(-9.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | 35.84%(-55.4%) |
| Jun 2022 | - | 80.33%(+0.2%) |
| Mar 2022 | - | 80.18%(+5.7%) |
| Dec 2021 | 72.97%(-30.6%) | - |
| Dec 2021 | - | 75.86%(-35.0%) |
| Sep 2021 | - | 116.68%(+110.5%) |
| Jun 2021 | - | 55.43%(+48.2%) |
| Mar 2021 | - | 37.40%(+76.5%) |
| Dec 2020 | 105.18% | 21.19% |
FAQ
- What is Neumora Therapeutics annual return on equity?
- What is the all time high annual ROE for Neumora Therapeutics?
- What is Neumora Therapeutics annual ROE year-on-year change?
- What is Neumora Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Neumora Therapeutics?
- What is Neumora Therapeutics quarterly ROE year-on-year change?
What is Neumora Therapeutics annual return on equity?
The current annual ROE of NMRA is -84.92%
What is the all time high annual ROE for Neumora Therapeutics?
Neumora Therapeutics all-time high annual return on equity is 105.18%
What is Neumora Therapeutics annual ROE year-on-year change?
Over the past year, NMRA annual return on equity has changed by -34.62% (-68.83%)
What is Neumora Therapeutics quarterly return on equity?
The current quarterly ROE of NMRA is -68.98%
What is the all time high quarterly ROE for Neumora Therapeutics?
Neumora Therapeutics all-time high quarterly return on equity is 116.68%
What is Neumora Therapeutics quarterly ROE year-on-year change?
Over the past year, NMRA quarterly return on equity has changed by +4.65% (+6.32%)